Please login to the form below

Not currently logged in
Email:
Password:

Kim Lemon appointed head of Liberation Unlimited

Will lead rebrand of Communiqué award-winning agency
Kim Lemon, Liberation

Liberation Unlimited has named former associate director Kim Lemon as its new head.

The announcement comes a few weeks after Liberation Communications changed its name to Liberation Unlimited as part of a rebrand of its parent group Creston Health, which is now known as Health Unlimited.

Lemon spent five years as associate director at Liberation having joined the company in 2009 from Athena Medical PR where she served as senior account manager. She also has experience in industry at the Johnson & Johnson subsidiary Lifescan.

Catherine Warne, CEO of Health Unlimited said: “Over the last year, and particularly in the last five months, Kim has become a figurehead for the agency.

“She has taken the lead on the development of a strong business plan for the agency, the roll-out of Liberation Unlimited and completely fresh branding, which will be launched in the New Year.” 

During her time at Liberation Lemon helped the agency to the Small Consultancy or Health Team of the Year award at the 2014 Communiqué Awards. She also led the PR team that won the Cello Health Award for Launch Excellence at the recent PMEA for its work on Bayer's Eylea.

11th December 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...

Latest intelligence

Market Shaping for Better Healthcare Decisions
82% of healthcare business professionals agreed that it is important to get market shaping right to achieve future brand success....
launch engagement
Launch engagement
How the pandemic is forcing a fresh focus on the human touch and fresh thinking about engagement...
Everything you need to know about patient groups and clinical trials
Patient advocacy groups (PAGs) and pharma/biopharma/biotech and MedTech industries are all working towards the same goal: to improve health outcomes. And as PAGs are key stakeholders in the clinical trial...